APA (7th ed.) Citation

Ashraf K. El-Damasy, Hyun Ji Kim, Jung Woo Park, Yunju Nam, Wooyoung Hur, Eun-Kyoung Bang, & Gyochang Keum. (2023). Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ashraf K. El-Damasy, Hyun Ji Kim, Jung Woo Park, Yunju Nam, Wooyoung Hur, Eun-Kyoung Bang, and Gyochang Keum. Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a Potent Pan-BCR-ABL Inhibitor Including the T315I Gatekeeper Resistant Mutant. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Ashraf K. El-Damasy, et al. Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a Potent Pan-BCR-ABL Inhibitor Including the T315I Gatekeeper Resistant Mutant. Taylor & Francis Group, 2023.